Exploring Non-Coding RNA Signatures in Cancer: Definitions and Implications for Diagnosis and Therapy
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 20 August 2025 | Viewed by 179
Special Issue Editors
Interests: leukemia; long non-coding RNA; circular RNA; hematopoietic stem cells; transplantation; xenograft
Special Issues, Collections and Topics in MDPI journals
Interests: cancer biology; chronic myelomonocytic leukemia (CMML); signaling pathways in metastasis; metabolism and transcriptome; zebrafish model
Special Issue Information
Dear Colleagues,
This Special Issue aims to consolidate current research on the identification and characterization of non-coding RNA (ncRNA) signatures in various cancers. Non-coding RNAs, including microRNAs (miRNAs), long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs), play crucial roles in the regulation of gene expression and have been implicated in cancer pathogenesis, diagnosis and treatment. We welcome original research articles, reviews and communications that cover these aspects. Additionally, we encourage submissions that investigate the underlying mechanisms by which ncRNAs influence cancer progression and response to treatment.
Dr. Amog Urs
Dr. Udhayakumar Gopal
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- non-coding RNA
- biomarkers
- gene regulation
- microRNA
- long non-coding RNA
- circular RNA
- therapeutic targets
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
